Skip to content
10-Q

Quarterly Report

GFR PHARMACEUTICALS INC

0001437749-12-008173

← back to feed
Filed
Aug 10, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 8, 2012 42.08M sh
Capex Q2 2012 · Jun 30, 2012 $1.49K
Capex Q2 2012 · Jun 30, 2011 $200.6K
Operating Cash Flow Q2 2012 · Jun 30, 2012 $43.75K
Operating Cash Flow Q2 2012 · Jun 30, 2011 $272.01K
Cash And Equivalents Q2 2012 · Jun 30, 2012 $505.55K
Cash And Equivalents Q2 2012 · Dec 31, 2011 $460.88K
Cash And Equivalents Q2 2012 · Jun 30, 2011 $383.76K
Cash And Equivalents Q2 2012 · Dec 31, 2010 $300.72K
Stockholders Equity Q2 2012 · Jun 30, 2012 $9.39M
Stockholders Equity Q2 2012 · Dec 31, 2011 $8.52M
Current Liabilities Q2 2012 · Jun 30, 2012 $965.88K
Current Liabilities Q2 2012 · Dec 31, 2011 $2.28M
Total Liabilities Q2 2012 · Jun 30, 2012 $1.81M
Total Liabilities Q2 2012 · Dec 31, 2011 $3.12M
Current Assets Q2 2012 · Jun 30, 2012 $1.07M
Current Assets Q2 2012 · Dec 31, 2011 $1.09M
Total Assets Q2 2012 · Jun 30, 2012 $11.94M
Total Assets Q2 2012 · Dec 31, 2011 $12.33M
Sga Expense Q2 2012 · Jun 30, 2012 $201.28K
Sga Expense Q2 2012 · Jun 30, 2012 $431.5K
Sga Expense Q2 2012 · Jun 30, 2011 $55.63K
Sga Expense Q2 2012 · Jun 30, 2011 $387.66K
Net Income Q2 2012 · Jun 30, 2012 $522.48K
Net Income Q2 2012 · Jun 30, 2012 $839.77K
Net Income Q2 2012 · Jun 30, 2011 $725.53K
Net Income Q2 2012 · Jun 30, 2011 $1.04M
Operating Income Q2 2012 · Jun 30, 2012 $723.57K
Operating Income Q2 2012 · Jun 30, 2012 $1.15M
Operating Income Q2 2012 · Jun 30, 2011 $953K
Operating Income Q2 2012 · Jun 30, 2011 $1.37M
Gross Profit Q2 2012 · Jun 30, 2012 $990.67K
Gross Profit Q2 2012 · Jun 30, 2012 $1.72M
Gross Profit Q2 2012 · Jun 30, 2011 $1.03M
Gross Profit Q2 2012 · Jun 30, 2011 $1.75M
Cost Of Revenue Q2 2012 · Jun 30, 2012 $207.28K
Cost Of Revenue Q2 2012 · Jun 30, 2012 $393.38K
Cost Of Revenue Q2 2012 · Jun 30, 2011 $191.86K
Cost Of Revenue Q2 2012 · Jun 30, 2011 $406.64K